The ATP binding cassette (ABC) transporter superfamily comprises a large family of transmembrane proteins that transport a variety of substrates across membranes coupled with ATP hydrolysis. 1, 2) This superfamily is related to the drug resistance of cancer cells and pathogens, immune responses and some congenital disorders. [3] [4] [5] Human ABC transporters have been classified into seven subfamilies (A-G) based on the sequences and organizations of their ATP binding domains.
The ATP binding cassette (ABC) transporter superfamily comprises a large family of transmembrane proteins that transport a variety of substrates across membranes coupled with ATP hydrolysis. 1, 2) This superfamily is related to the drug resistance of cancer cells and pathogens, immune responses and some congenital disorders. [3] [4] [5] Human ABC transporters have been classified into seven subfamilies (A-G) based on the sequences and organizations of their ATP binding domains. 6, 7) Subfamily B consists of half-and fulltype transporters, well-characterized members being transporter associated with antigen processing (TAP) 8) and multidrug resistance (MDR), 9) respectively. The members of this subfamily transport a variety of cationic substrates of different sizes, from iron to antibiotics, anti-tumor compounds and antigenic polypeptides.
TAPL (TAP-like; ABCB9) is strongly homologous to TAP1 and TAP2; 60 and 62%, respectively, of their amino acid residues are conserved. 10) From such similarity, it is expected that a potential function of TAPL could be associated with peptide transport like in the case of TAP. Furthermore, it is noteworthy that TAPL is highly conserved in rodents and man (95% identity in amino acid residues), compared with TAP1 and TAP2 (75% and 77% identity, respectively), suggesting that the evolutional rate of TAPL was much slower than those of TAP1 and TAP2, although TAPL could have diverged from an ancestor of TAP. 11) Recently we found the novel splicing isoforms with different carboxyl-terminal sequences in rat and human, 12, 13) although the major isoform was originally reported one.
Most of the half-type ABC transporters are localized to intracellular organelle membranes and function as either homodimers or heterodimers. [14] [15] [16] In this study we examined the cellular distributions of TAPL and its family members (TAP1 and TAP2), and their mutual interactions by monitoring the fluorescence derived from fluorescent proteins fused downstream of the carboxyl terminal cytoplasmic ABC region or of the amino terminal transmembrane region. Although TAP1 and TAP2 form a heterodimer, [17] [18] [19] [20] and TAPL, TAP1 and TAP2 show strong sequence similarity to each other, 11) it has not been determined whether TAPL forms a heterodimer or a homodimer.
MATERIALS AND METHODS
Cell Culture, Transfection and Preparation of Total RNA Cells were grown in Dulbecco's modified Eagle's medium (GIBCO BRL) containing 7% (v/v) fetal bovine serum (JRH Bioscience). COS-1 cells (ATCC) 21) were transfected by the DEAE-dextran method as described previously. 22) HEK-293 cells (2-5ϫ10 5 cells/F 60 mm dish) (RIKEN Cell Bank) 23) were transfected by the cationic lipid method using 2.5 mg/dish plasmid DNA with UltraFector or SuperFector (B-bridge), as recommended by the manufacturer. Cells were further grown for 24 h, and then subjected to Western blotting or microscopic observation.
Total RNA was extracted with Isogen (Wako Chemicals) 24) from HEK-293 cells cultured in two F10 cm dishes. First strand cDNA was synthesized from 5 mg of RNA with a SuperScript Preamplification System (Gibco BRL) with the oligo dT 15 primer, and 1 ml of reaction product was subjected to polymerase chain reaction (PCR). Complimentary DNAs for human TAP1,  TAP2 , and TAPL were amplified by means of the PCR method with Ampli Taq polymerase (Perkin Elmer) and primers (Fig. 1A) carrying a Bgl II site upstream of the initiation codon and a Sal I or Xho I site instead of the termination codon, respectively. TAP1 cDNA (a kind gift from H. Furukawa) for TAP1, and the reverse transcriptase-PCR products described above for TAP2 and TAPL were used as templates. The PCR conditions in general were 35 cycles of denaturation (94°C, 1 min), annealing (64°C, 1 min), and extension (72°C, 3 min). Dimethyl sulfoxide (5%, v/v) was added to the reaction mixture. For PCR in the present study, preheating (94°C, 3 min) and post-incubation (72°C, 7 min) were always carried out before and after successive cycle reactions, respectively. The amplified cDNAs were size-separated on an agarose gel [0.8%, (w/v) Takara Type L03] using (1X) TAE buffer [40 mM Tris-acetate, 1 mM EDTA (pH 8.0)], 26) and the DNA fragments (2406 bp, 2136 bp and 2332 bp for TAP1, TAP2 and TAPL, respectively) were eluted with Geneclean III (Bio 101). They were ligated to the pGEM-T Easy vector (Promega, WI) with T4 DNA ligase. Both strands of cloned DNAs were sequenced by the dideoxy chain-termination method 27) using an ABI PRISM 310 sequencer with a Thermo Sequenase fluorescent labeled primer cycle sequencing kit (Amersham Pharmacia Biotech).
25)

Construction of Plasmids for TAP1/2/L-GFP and TAP1/2/L-DR
The sequences of cloned DNA fragments were identical to those previously published for TAPL 10, 11) and TAP1.
28)
TAP2 29) had conservative substitutions 30) at the 490th (A→T) and 654th (H→R) codons for the carboxyl terminal region. However, such substitutions did not affect the results for TAP2-S-green fluorescence protein (GFP) carrying only the M 1 -R 88 region. Thus, the Bgl II-Sal I fragments of TAP1 and TAPL, and the Bgl II-Xho I fragment of TAP2 were inserted into the corresponding sites of mammalian fluorescence protein expression vectors pEGFP-N1 and pDsRed1-N1 (CLONTECH). The resulting plasmids were named pTAP1/2/L-GFP and pTAP1/2/L-DsRed (DR), respectively.
Construction of Plasmids for Carboxyl Terminal Truncated Forms of TAP1/2/L-GFP Expression plasmids for carboxyl terminal truncated TAP1/2/L-GFP were constructed by deletion of the segment carrying the ABC region together with (TAP1/2/L-S-GFP) or without the carboxyl terminal half of the transmembrane region (TAP1/2/L-L-GFP) (Fig.  1B) . After digestion with restriction enzymes, large DNA fragments were purified from the agarose gel as described above, and then self-ligated with T4-DNA ligase; the restriction enzymes used were Apa I and Sma I (pTAPL-S-GFP), Sma I and Hin dIII (pTAPL-L-GFP), Bsp EI and Xma I (pTAP1-S-GFP), Bam HI and Pml I (pTAP1-L-GFP), Sma I and Pml I (pTAP2-S-GFP), and Bam HI (pTAP2-L-GFP). To construct pTAPL-S-GFP, T4 DNA polymerase treatment was carried out after restriction enzyme digestion. Similarly, endfilling of the fragments was carried out with the Klenow enzyme in the presence of dNTPs for pTAPL-L-GFP and pTAP1-L-GFP. To confirm the DNA sequences after manipulation, short segments carrying ligation sites were digested with appropriate restriction enzymes, subcloned and sequenced. Other molecular biological methods for DNA manipulations were based on standard procedures.
26)
Western Blotting Analysis Cytosol and membrane fractions were prepared from HEK-293 cells at 4°C. Cells were scraped with a rubber policeman into phosphate-buffered saline [10 mM sodium phosphate buffer (pH 7.2), 137 mM NaCl, 3 mM KCl], and collected by low speed centrifugation (1200ϫg, 5 min). The cell pellet was resuspended in 0.1 M Tris-HCl (pH 7.5) containing protease inhibitors (7 mg/ml pepstatin, 2.1 mM leupeptin, 10 mM benzamidine, 25 mg/ml aprotinin and 5 mM phenylmethylsulfonyl fluoride), and then homogenized with a Dounce homogenizer (60 strokes on ice). The suspension was centrifuged at 600ϫg for 2 min to remove nuclei and unbroken cells. The resulting supernatant was further centrifuged at 80000ϫg for 40 min (Beckman 50-3Ti rotor). The supernatant (soluble fraction) and pellet (postnuclear membrane fraction) were analyzed by Western blotting.
Proteins were subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel (10%, w/v) electrophoresis, 31) and then electroblotted onto Immobilon P (Millipore).
32) GFP-and DR-tagged proteins were reacted with rabbit polyclonal antibodies for GFP (1;2000 dilution, Boehringer Mannheim) and DsRed (1;2000 dilution, Boehringer Mannheim), respectively. Then they were detected by means of an Amersham 
ECL
TM Western blotting analysis system with anti-rabbit Ighorseradish peroxidase-linked antibodies (1;4000 dilution, Amersham Pharmacia Biotech). Protein was examined by means of a Bio-Rad Protein assay with bovine serum albumin (fraction V, Sigma) as a standard. 33) Microscopic Observation For fluorescence images, cells were visualized with an ORCA-1394 imaging system (Hamamatsu Photonics) mounted on a microscope, IX70 (Olympus), using the 488 nm excitation line of an Ar laser. Endoplasmic reticulum (ER), lysosome and nucleus staining was performed with Brefeldin A-BODIPY (Molecular Probes) (0.2 mg/ml), Lysotracker, Red DND-99 (Molecular Probes) (577/590 nm) (50 nM), and Hoechst 33342 (5 mg/ml), respectively.
Chemicals Restriction enzymes were purchased from New England Biolab (MA, U.S.A.) and TaKaRa Shuzo (Kyoto). T4 DNA ligase, T4 DNA polymerase and the Klenow enzyme were from Promega, TaKaRa and New England Biolab, respectively. PCR primers were purchased from GIBCO BRL and Invitrogen. Protease inhibitors were from Sigma. All other chemicals used were of the highest grade commercially available.
RESULTS
Membrane Localization of TAPL and Its Truncated Forms
We first examined which region of the TAPL is required for its membrane localization. Carboxyl terminal truncation mutants as well as full length TAPL fused to GFP were expressed in HEK-293 cells, in which the endogenous expression of TAP and TAPL mRNA were very low (data not shown). Then their distribution between the postnuclear membrane and soluble fractions was determined by Western blotting after fractionation. Both fractions were well separated under the experimental conditions, since Hsp90 (a cytoplasmic marker 34) ) and Bip (an ER membrane marker 35) ) showed the expected distributions (data not shown). The results clearly indicated that TAPL-GFP was abundant in the membrane fraction but not in the soluble fraction ( Fig. 2A) . The truncated versions of TAPL-GFP (TAPL-S-GFP and TAPL-L-GFP) were also distributed in the membrane fraction (Fig. 2B) .
Next we monitored the distribution of TAPL-GFP and its truncated version on the whole cell level by detecting fluorescence from the GFP moiety on microscopy. As shown in Fig. 3 (upper panels) , TAPL-GFP and TAPL-L-GFP showed essentially similar fluorescence patterns, the signal being localized to the intracellular membranes. However, interestingly, the fluorescence of TAPL-S-GFP was localized on not only intracellular but also plasma membranes, suggesting The averaged hydropathic index of a nonadecapeptide is plotted with a Kyte-Doolittle scale.
46) The potential transmembrane helices are numbered from the amino terminus based on the previous results for TAP1 and TAP. 28, 18) The last two helices 18) are counted in the present study. [TM, transmembrane region (containing membrane spanning helices); PB, putative peptide binding region; ABC, ATP binding cassette]. The diagrams show the constructs used in this study; full-length TAPL tagged at the carboxyl terminus with GFP (TAPL-GFP), amino acids 1-275 or 1-75 of TAPL tagged with GFP (TAPL-L-GFP and TAPL-S-GFP, respectively); full-length TAP1 tagged at the carboxyl terminus with GFP (TAP1-GFP), amino acids 1-315 or 1-97 of TAPL tagged with GFP (TAP1-L-GFP and TAP1-S-GFP, respectively); and full-length TAP2 tagged at the carboxyl terminus with GFP (TAP2-GFP), amino acids 1-225 or 1-88 of TAP2 tagged with GFP (TAP2-L-GFP and TAP2-S-GFP, respectively). Comparison of the Localization of TAPL with TAP1 and TAP2 To compare such properties of TAPL with those of related family members (TAP1 and TAP2), we carried out similar experiments. TAP1-GFP ( Fig. 2A) and its derivatives, TAP1-S-GFP and TAP1-L-GFP (Fig. 2B) , were only distributed in the membrane fraction. Furthermore, fluorescence microscopy demonstrated that they were all localized to the intracellular membranes (Fig. 3A, lower) . According to the membrane topology model of TAP1, 18) TAP1-S-GFP and TAP1-L-GFP should contain TM1 and TM1-6, respectively (Fig. 4) . Thus, the results suggest that the N-terminal region (M 1 -R 97 ) containing TM1 of TAP1 contains the signal for retention in the intracellular membranes in contrast to TAPL.
TAP2-GFP and TAP2-L-GFP were distributed not only in the membrane but also the soluble fraction (Figs. 2A, B) , possibly due to the unstable conformation of the TAP2 moiety without TAP1 in vivo 19, 36) and in vitro, 20) while the TAP1 molecule in TAP2-deficient cells was stable. 19, 37) Furthermore, TM6-9 of TAP2 was also localized in the cytosol, although TM1 of TAP2 was retained on the ER. 18) However, TAP2-S-GFP was definitely found in the membrane fraction (Fig. 2B, upper panels) . Intriguingly, TAP2-S-GFP was distributed on surface membranes as well as intracellular membranes, similar to TAPL-S-GFP (Fig. 3A) . Thus, TM1-2 (M 1 -R 88 ) of TAP2 (Fig. 4) has the ability of membrane retention, although the contribution of the downstream sequence should be carefully examined for TAP2. So we analyzed only TAP2-S-GFP further in the present study.
Change in the Distribution of TAPL-S-GFP and TAP2-S-GFP Caused by DsRed Fusions of TAPL and TAP1
It would be interesting to know whether TAPL is able to interact with itself and/or TAP1 and TAP2. We thought that TAPL-S-GFP could be a tool for detecting such interactions: if TAPL-S-GFP interacts with TAP1-DR, for example, the fluorescence of TAPL-S-GFP would be co-localized with that of TAP1-DR on the intracellular membranes, which would be a good indication of a protein-protein interaction. For this purpose we used COS-1 cells, since they were convenient for the analyses; they spread on and adhere to the dishes more tightly, and essentially the same membrane distributions of fusion proteins were obtained for COS-1 cells (Fig. 3B) . Furthermore, the RT-PCR experiment revealed that TAP and TAPL mRNAs expressed in COS-1 cells were not detectable (data not shown).
The fluorescence signal of TAPL-S-GFP was concentrated on the intracellular membranes, and co-localized with the red fluorescence of TAPL-DR and TAP1-DR (Fig. 5A) . This indicated that the amino terminal membrane region (TM1-2 covering M 1 -G
75
) of TAPL could be sufficient for the specific interaction with TAPL and TAP1. Similarly, TAPL-DR ) of TAP2 and affect its cellular distribution.
We further examined the effect of MAT8-DR: MAT8 is a single transmembrane protein related to anion channel activity. 38) As shown in Fig. 5B , expression of MAT8-DR did not affect the membrane distribution of TAP2-S-GFP. Thus, the change in the fluorescence distribution could be due to specific interaction of TM1-2 of TAPL and TAP2 with TAP1 and TAPL, and not to an interaction between fluorescence tags. It must be also mentioned that cellular distribution of MAT8-DR in the absence of TAP2-S-GFP was essentially the same as that in its presence (data not shown).
Co-localization of TAPL with Organelle Markers To determine whether or not TAPL is localized to a specific region of intracellular membranes, fluorescent organelle markers such as Brefeldin A-BODIPY (for ER), Lysotracker (for lysosome), and Hoechst 33342 (for nucleus) 39) were added to COS-1 cells expressing TAPL-GFP (Fig. 6 ). The ER marker Brefeldin A-BODIPY surrounded nuclei stained with Hoechst 33342, and showed that fluorescence pattern overlapped that of TAPL-GFP. On the other hand, Lysotracker showed a partially overlapped but distinct fluorescence pattern compared with that of TAPL-GFP.
The same experiments were performed with TAP1-GFP and TAP2-GFP. TAP1-GFP was co-localized with ER marker Brefeldin A BODIPY around nuclei stained with Hoechst 33342, and partially overlapped the fluorescence of Lysotracker (Fig. 6) . In contrast to TAPL-GFP and TAP1-GFP, TAP2-GFP showed a different fluorescence pattern. The fluorescence of TAP2-GFP did not overlap that of ER marker or Lysosome marker, which was consistent with the result of Western blotting analysis (Fig. 2) . ; TM1-6) showed similar localization, suggesting that the amino terminal portion of the transmembrane region is critical for the intracellular membrane localization of TAPL and TAP1.
DISCUSSION
As for TAP1, the amino terminal TM1 region (M 1 -R 97 ) was enough for its localization to the ER membrane, consistent with the previous observation.
18 ) The truncated TAPL (M ; TM1-2) with similar regions were distributed on the plasma membrane in addition to the intracellular membranes. Thus, these two proteins need additional regions for their targeting (or retention) to the intracellular membranes, although membrane-localizing signals are present in the TM1-2 regions. Actually, the following transmembrane region of TAPL (P 76 -S 275 ; TM3-6) played an important role in its localization to the intracellular membranes. However, it is also possible that TM1-2 would form a localization signal in the presence of the downstream TM3-6 sequence.
Full-length TAPL and TAP1 attracted TAPL-S-GFP and TAP2-S-GFP to the intracellular membranes, indicating that the necessary information for protein-protein interaction could be present in the amino termini of TAPL and TAP2 (M 1 -G 75 and M 1 -R 88 , respectively). TM1-6 of TAP1 could participate in the interaction with TAP2. 18) Thus, TAPL would also donate such a transmembrane region(s) for its homo-and hetero-dimerization. Since the heteromeric structure of TAP (TAP1 and TAP2) is important for the ATP-dependent peptide transport cycle, 40) comparison of the transport activity and higher ordered-structure of TAPL as a homodimer (TAPL-TAPL) and a heterodimer (TAPL-TAP1 and TAPL-TAP2) with those of the TAP1-TAP2 heterodimer would be interesting.
The fluorescence signals of TAPL-GFP and TAP1-DR were clearly co-localized to the intracellular membranes. It has been established that TAP1 is targeted mainly to the ER under various experimental conditions. 14, 17, 41, 42) Actually, the co-localization with the fluorescent organelle markers suggested that TAPL-GFP and TAP1-GFP are mainly localized on the ER. Considering our previous finding that transientlyexpressed TAPL-GFP was co-localized with protein disulfide isomerase (PDI) (a marker protein of ER), 11) TAPL could be retained on the ER membrane.
Although TAPL as well as TAP1 and TAP2 do not have an apparent ER retention signal such as a carboxyl-terminal K/HDEL sequence or dilysine motifs, 43) it has been suggested that TAP1 and TAP2 have multiple redundant ER retention signals throughout TM1-6 and TM1-5, respectively. 18) This might partly explain why TAPL-S-GFP and TAP2-S-GFP with TM1-2 regions were distributed further to the plasma membrane. Our study also suggests that TAPL, TAP1 and TAP2 could be localized on membranes related to vesicular transport, since they were found in the intracellular membranes, mainly in the ER and scarcely in lysosome, and plasma membranes depending on the conditions such as truncation. It has been reported that human ABCB9 expressed stably in a human ovarian carcinoma cell line was localized to lysosome. 44) Recently, it was demonstrated, with a human melanoma cell line, that human TAP1 tagged with GFP at its cytosolic terminus showed typical fluorescence staining of the ER and the ability of peptide transport through the ER membrane for antigen presentation together with TAP2. 41) A similar fluorescence tag for TAPL would also be useful for determining protein-protein interactions in the case of difficulty in preparing antibodies 45) and detection of a dimer in vitro.
